These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 7850821)

  • 41. Evaluation of cilazapril versus captopril in patients with mild to moderate essential hypertension.
    Stevenson JG; Chideckel EW
    Clin Exp Hypertens; 1994 Mar; 16(2):179-96. PubMed ID: 8193609
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Direct Renin inhibition with aliskiren in obese patients with arterial hypertension.
    Jordan J; Engeli S; Boye SW; Le Breton S; Keefe DL
    Hypertension; 2007 May; 49(5):1047-55. PubMed ID: 17353513
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The effect of cilazapril, a new angiotensin converting enzyme inhibitor, on peak and trough blood pressure measurements in hypertensive patients.
    Güntzel P; Kobrin I; Pasquier C; Zimlichman R; Viskoper JR
    J Cardiovasc Pharmacol; 1991 Jan; 17(1):8-12. PubMed ID: 1708060
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A dose escalation trial comparing the combination of diltiazem SR and hydrochlorothiazide with the monotherapies in patients with essential hypertension.
    Weir MR; Weber MA; Punzi HA; Serfer HM; Rosenblatt S; Cady WJ
    J Hum Hypertens; 1992 Apr; 6(2):133-8. PubMed ID: 1597846
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antihypertensive and metabolic effects of single and combined atenolol regimens.
    Chrysant SG; Chappel C; Farnham DJ; Levin B; Lueg M; McCluskey D; Steiner C
    J Clin Pharmacol; 1992 Jan; 32(1):61-5. PubMed ID: 1740538
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A double-blind, randomized, placebo-controlled comparison of the metabolic effects of low-dose hydrochlorothiazide and indapamide.
    Elliott WJ; Weber RR; Murphy MB
    J Clin Pharmacol; 1991 Aug; 31(8):751-7. PubMed ID: 1880234
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pharmacokinetics and pharmacodynamics of drospirenone-estradiol combination hormone therapy product coadministered with hydrochlorothiazide in hypertensive postmenopausal women.
    Karara AH; Hanes V; Alonso A; Ni P; Poola N; Silang R; Blode H; Preston RA
    J Clin Pharmacol; 2007 Oct; 47(10):1292-302. PubMed ID: 17906162
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Treatment of hypertension in the very old.
    Otterstad JE; Ruilope LM
    Int J Clin Pract Suppl; 2000 Nov; (114):10-9. PubMed ID: 11221289
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of cilazapril with or without low dose thiazide on LDL peroxidation in [correction of peroxidationin] hypertensive patients.
    Hussein O; Radan A; Reuven V
    Am J Hypertens; 2003 Sep; 16(9 Pt 1):734-8. PubMed ID: 12944031
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The efficacy and tolerability of enalapril in a formulation with a very low dose of hydrochlorothiazide in hypertensive patients resistent to enalapril monotherapy.
    Guul SJ; Os I; Jounela AJ
    Am J Hypertens; 1995 Jul; 8(7):727-31. PubMed ID: 7546499
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Moxonidine and hydrochlorothiazide in combination: a synergistic antihypertensive effect.
    Frei M; Küster L; Gardosch von Krosigk PP; Koch HF; Küppers H
    J Cardiovasc Pharmacol; 1994; 24 Suppl 1():S25-8. PubMed ID: 7533223
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of cilazapril on renal haemodynamics and function in hypertensive patients: a randomised controlled study versus hydrochlorothiazide.
    Scaglione R; Ganguzza A; Corrao S; Costa R; Paternà S; Cannavo MG; Parrinello G; Di Chiara T; D'Aubert MD; Cottone C
    Blood Press; 1995 Nov; 4(6):363-8. PubMed ID: 8746604
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Efficacy of cilazapril compared with hydrochlorothiazide in the treatment of mild-to-moderate essential hypertension. Multicentre Study Group.
    Morgan TO
    Am J Med; 1989 Dec; 87(6B):37S-41S. PubMed ID: 2532459
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Labetalol and hydrochlorothiazide in hypertension. Labetalol/Hydrochlorothiazide Multicenter Study Group.
    Clin Pharmacol Ther; 1985 Jul; 38(1):24-7. PubMed ID: 2860990
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Antihypertensive effects of indoramin and prazosin in combination with hydrochlorothiazide.
    Solomon R
    J Cardiovasc Pharmacol; 1986; 8 Suppl 2():S56-62. PubMed ID: 2423799
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cilazapril: an overview of its efficacy and safety in hypertension.
    Szucs T; Schneeweiss A
    Cardiology; 1992; 80(1):34-41. PubMed ID: 1532534
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pharmacokinetics and effects on renal function following cilazapril and hydrochlorothiazide alone and in combination in healthy subjects and hypertensive patients.
    Nilsen OG; Sellevold OF; Romfo OS; Smedsrud A; Grynne B; Williams PE; Kleinbloesem CH
    Br J Clin Pharmacol; 1989; 27 Suppl 2(Suppl 2):323S-328S. PubMed ID: 2527546
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Left ventricular mass, serum electrolyte levels and cardiac arrhythmias in patients with mild hypertension treated with cilazapril or hydrochlorothiazide.
    Lumme JA; Jounela AJ
    Int J Cardiol; 1993 Nov; 42(1):71-8. PubMed ID: 7509325
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Dose response to hydrochlorothiazide in hypertensives receiving a calcium channel blocker.
    Ziegler MG; Lernhardt E; Solt-Buzsaki V
    Clin Exp Hypertens A; 1988; 10(5):791-800. PubMed ID: 3180489
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Treatment of essential hypertension with PN 200-110 (isradipine).
    Hamilton BP
    Am J Cardiol; 1987 Jan; 59(3):141B-145B. PubMed ID: 2949585
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.